Join Lonza's experts during a scientific program presentation and schedule a meeting to discuss your next project at our virtual booth. 

The 12th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology is a high-class scientific congress with the accompanying exhibition ResearchPharm. This conference has gained an ever-increasing impact among the pharmaceutical scientists: With more than 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world. Learn more about the event here.
 
 
We hope you can join us for the following virtual presentation. Mark your calendar!
  
 

Program presentations:

David Lyon

 

David Lyon, Ph.D., Senior Fellow, Global R&D

 

Subject Matter Expert: Bioavailability Enhancement

David Lyon serves as a Senior Fellow, Global R&D, at Lonza’s site in Bend, Oregon, USA, where he advises on internal and external collaborations for bioavailability enhancement technologies, modified release, and bioprocessing. David joined Bend Research as a Research Chemist in 1991. Read more

 

In Vitro Test Methodologies for Characterizing Bioavailability Enhancing Formulations

Wednesday, 12 May 2021. 4:45pm - 5:05pm (CEST)
 
About the presentation:
Amorphous solid dispersions (ASDs) are a leading technology option for improving oral bioavailability of poorly soluble compounds. In vitro methods for predicting the bioperformance of ASDs will be discussed during this presentation.
 

Rational selection of Amorphous Solid Dispersion (ASD) Compositions for Improving Drug Candidate Bio-performance

Thursday, 13 May 2021, 3:35pm - 4:25pm (CEST)
 
About the presentation: 
Low aqueous drug solubility in the pharmaceutical pipelines is a pervasive issue. In particular, rapidly growing therapeutic areas including oncology, anti-virals and anti-inflammatory indications are largely plagued by low solubility. As a result, a number of enabling technologies have been developed to improve oral drug absorption and bioavailability (BA). However, in recent years the most notable commercial products are those that utilize amorphous solid dispersions (ASD). This talk will address ASD technology and in vitro methodologies for rationally selecting ASD formulations. In vitro- in vivo correlations will be discussed.
  
 
 
Meet 1-2-1 with our expert in the virtual event: schedule a session.
 
 

 
Can’t attend the virtual event? Access other relevant technical content in our Knowledge Center:
  • Live webinar "Scale-up and commercialization of spray-dried amorphous solid dispersions", registration
  • On-demand webinar "Solid form screening and rational cocrystal design", watch now
  • On-demand webinar "Enabling streamlined formulation development of amorphous solid dispersion drug products", watch now
  • Whitepaper/executive summary "Solid form screening: a key drug development step", read now


    

 

Lorem ipsum dolor sit amet